(Press-News.org) Embargoed for release until 5:00 p.m. ET on Monday 15 September 2025
Follow @Annalsofim on X, Facebook, Instagram, Bluesky, and Linkedin
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
----------------------------
1. Tirzepatide more cost-effective than semaglutide in patients with knee osteoarthritis and obesity
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-24-03609
Editorial: https://www.acpjournals.org/doi/10.7326/ANNALS-25-03113
URL goes live when the embargo lifts
A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs), semaglutide and tirzepatide, for patients with osteoarthritis and obesity compared with usual care, diet and exercise, and weight loss surgeries. The study found that both semaglutide and tirzepatide would be cost-effective compared with usual care, with tirzepatide offering a more favorable return on investment. The results suggest tirzepatide would be more economical than semaglutide at current net prices. The study is published in Annals of Internal Medicine.
Researchers from the Orthopaedic and Arthritis Center for Outcomes Research at Brigham and Women’s Hospital assessed cost-effectiveness of GLP1RAs and other weight loss interventions in patients with knee osteoarthritis and obesity using the Osteoarthritis Policy (OAPol) Model, a validated and widely published Monte Carlo microsimulation of knee osteoarthritis. Model parameters were derived from the STEP (Semaglutide Treatment Effect in People with Obesity)-9 study. Primary outcomes were lifetime quality-adjusted life-years (QALYs), medical costs in 2024 U.S. dollars, and incremental cost-effectiveness ratios (ICERs). They examined six clinical strategies: usual care (UC), UC plus diet and exercise, UC plus semaglutide, UC plus tirzepatide, UC plus laparoscopic sleeve gastrectomy (LSG), and UC plus Roux-en-Y gastric bypass (RYGB). For everyone on a weight loss regimen, the model assigned a BMI and pain reduction level along with a probability of adverse events based on published clinical trial data or secondary analyses of data from randomized clinical trials. The researchers derived weight loss associated with semaglutide from the STEP-5 and STEP-2 trials and weight loss for tirzepatide from the SURMOUNT-4 (A Study of Tirzepatide in Participants With Obesity or Overweight for the Maintenance of Weight Loss) and SURMOUNT-2 (A Study of Tirzepatide in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight) trials. In the primary analysis excluding surgical strategies, the researchers found that UC led to 9.59 QALYs compared with 9.75 for diet and exercise, 10.48 for semaglutide, and 10.68 for tirzepatide. Adding diet and exercise to UC resulted in an ICER of $25,400 per QALY, whereas adding tirzepatide produced an ICER of $57, 400 per QALY. Tirzepatide provided greater clinical benefit at lower costs when analyzed incrementally compared to semaglutide. In the secondary analysis, the researchers found that for persons with BMI>35 kg/m2, RYGB would offer the best return on investment for cost-effectiveness thresholds above $30,700 per QALY, which may stem from the long-term weigh maintenance seen after weight loss surgery compared to GLP1RA medications. These findings should inform discussions between clinicians and patients on the differences between these weight loss interventions, their potential benefits and harms, and currently available knee osteoarthritis care options for persons with BMI>30 kg/m2 and symptomatic knee osteoarthritis.
Media contacts: For an embargoed PDF, please contact Gabby Macrina at gmacrina@acponline.org. To contact corresponding author Elena Losina, PhD please email Haley Bridger at hbridger@mgb.org.
----------------------------
2. Despite commercial availability, evidence of benefits, accuracy, and harms of multicancer detection tests is unclear
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-01877
Editorial: https://www.acpjournals.org/doi/10.7326/ANNALS-25-03530
URL goes live when the embargo lifts
A systematic review assessed the benefits, accuracy, and harms of screening with blood-based multicancer detection (MCD) tests in asymptomatic adults. The review revealed that no controlled studies that report benefits of MCD test screening have been completed, and there was insufficient evidence to evaluate harms and accuracy. The findings can inform focus areas for additional research on MCD tests. The review is published in Annals of Internal Medicine.
Researchers from RTI–University of North Carolina Evidence-Based Practice Center and The Ohio State University College of Medicine aimed to review and analyze controlled studies of MCD tests in asymptomatic populations reporting cancer detection, mortality, quality of life, and harms (psychosocial, adverse events, decrease in standard-of-care screening); uncontrolled studies for harms of diagnostic evaluation; and test accuracy studies completed between 1 January 2013 and 26 December 2024. The researchers did not identify any completed controlled studies of MCD tests for screening. For test accuracy, the researchers included 20 unique studies reporting on 19 unique MCD tests. They found that accuracy varied widely based on study design, type of cancer the MCD test was designed to report, and subgroups of participants. One controlled study reported on one harm of screening outcome and two harms of diagnostic evaluation outcomes; however; the strength of the evidence reported was deemed insufficient due primarily to study limitations and unknown or inconsistent findings. Despite limited or insufficient evidence to support the widespread adoption of MCD tests, some tests are commercially available. To address gaps in knowledge, the reviewers say future research should include empirical studies on 1) surrogate outcomes for cancer-specific mortality, 2) benefits and harms of MCD tests in various populations, 3) harms and cost-effectiveness, 4) the optimal timing of use and intervals for rescreening, and 5) communicating benefits and risks for screening with MCD tests to clinicians and patients. Results from this review can inform clinical and policy decision making by clinicians, medical professional organizations, guideline developers, health care payers, and other groups or organizations.
Media contacts: For an embargoed PDF, please contact Gabby Macrina at gmacrina@acponline.org. To contact corresponding author Leila C. Kahwati, MD, MPH please email news@rti.org.
----------------------------
END
Tirzepatide more cost-effective than semaglutide in patients with knee osteoarthritis and obesity
2025-09-15
ELSE PRESS RELEASES FROM THIS DATE:
GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity
2025-09-15
• Analysis led by Mass General Brigham researchers shows tirzepatide offers greater value than semaglutide for most patients
• For eligible and willing patients, bariatric surgery provides the best option from a clinical and economic perspective
A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, ...
Interactive apps, AI chatbots promote playfulness, reduce privacy concerns
2025-09-15
UNIVERSITY PARK, Pa. — The more interactive a mobile app or artificial intelligence (AI) chatbot is, the more playful they are perceived to be, with users letting their guard down and risking their privacy, according to a team led by researchers at Penn State.
The researchers studied the effect of mobile app interactivity on users’ vigilance toward privacy risks during the sign-up process, and how this shapes their attitudes toward the app and their willingness to keep using it. The team found that interactivity motivates users to engage with the app by fostering a heightened sense of playfulness and lowering their privacy ...
How NIL boosts college football’s competitive balance
2025-09-15
A groundbreaking new study published in Management Science challenges conventional wisdom about Name, Image, and Likeness (NIL) policies in college football, demonstrating they actively enhance competitive balance and broaden opportunities for athletes. Researchers Tim Derdenger from Carnegie Mellon University’s Tepper School of Business and Ivan Li at the Naveen Jindal School of Management, University of Texas at Dallas, find that NIL has led to a wider distribution of talent across college programs, directly benefiting athletes who seek to maximize their brands and earning potential. This research overturns the “rich get richer” narrative, asserting ...
Moffitt researchers develop machine learning model to predict urgent care visits for lung cancer patients
2025-09-15
TAMPA, Fla. (Sept. 15, 2025) — A new study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with non–small cell lung cancer are most at risk of needing urgent care during treatment. The study was led by researchers and clinicians at Moffitt Cancer Center.
Patients undergoing systemic therapy for non-small cell lung cancer often experience treatment-related toxicities that can result in unplanned urgent care visits. In this study, Moffitt researchers tested whether integrating multiple ...
Construction secrets of honeybees: Study reveals how bees build hives in tricky spots
2025-09-15
On a hot summer day in Colorado, European honeybees (Apis mellifera L.) buzz around a cluster of hives near Boulder Creek. Worker bees taking off in search of water, nectar and pollen mingle with bees that have just returned from the field. Inside the hives, walls of hexagons are beginning to take shape as the bees build their nests.
“Building a hive is a beautiful example of honeybees solving a problem collectively,” said Orit Peleg, associate professor in CU Boulder’s Department of Computer Science. “Each bee has a little bit of wax, and each bee knows where to deposit it, ...
Wheat disease losses total $2.9 billion across the United States and Canada between 2018 and 2021
2025-09-15
A new multiyear study has revealed that between 2018 and 2021, wheat diseases caused the loss of approximately 560 million bushels—valued at US$2.9 billion, or $18.10 per acre, in farmer revenue—across 29 U.S. states and Ontario, Canada.
Published in Plant Health Progress™, the study was led by Andrew Friskop (Department of Plant Pathology, North Dakota State University) in collaboration with dozens of university-based specialists and the Crop Protection Network. It represents the most comprehensive survey of wheat-related losses to date. The findings underscore the widespread economic impact of ...
New funding fuels development of first potentially regenerative treatment for multiple sclerosis
2025-09-15
Toronto, ON (September 15, 2025) – A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance a promising therapy for multiple sclerosis (MS). Supported by Brain Canada, the National MS Society’s Fast Forward program, and Health Canada through the Canada Brain Research Fund, the project is developing a novel approach to treatment that may halt disease progression and repair nerve damage and restore function.
Around ...
NJIT student–faculty team wins best presentation award for ant swarm simulation
2025-09-15
Think twice about eliminating those pesky ants at your next family picnic. Their behavior may hold the key to reinventing how engineering materials, traffic control and multi-agent robots are made and utilized, thanks to research conducted by recent graduate Matthew Loges ’25 and Assistant Professor Tomer Weiss from NJIT's Ying Wu College of Computing.
The two earned a best presentation award for their research paper titled “Simulating Ant Swarm Aggregations Dynamics” at the ACM SIGGRAPH Symposium for Computer Animation (SCA), and a qualifying poster nomination for the undergraduate research competition at the 2025 ACM SIGGRAPH conference.
SIGGRAPH, ...
Ants defend plants from herbivores but can hinder pollination
2025-09-15
Around 4,000 plant species from different parts of the world secrete nectar outside their flowers, such as on their stems or leaves, through secretory glands known as extrafloral nectaries. Unlike floral nectar, extrafloral nectar does not attract pollinators; rather, it attracts insects that defend plants, such as ants. These insects feed on the sweet liquid and, in return, protect the plant from herbivores. However, this protection comes at a cost.
A study published in the Journal of ...
When the wireless data runs dry
2025-09-15
To train artificial intelligence (AI) models, researchers need good data and lots of it. However, most real-world data has already been used, leading scientists to generate synthetic data. While the generated data helps solve the issue of quantity, it may not always have good quality, and assessing its quality has been overlooked.
Wei Gao, associate professor of electrical and computer engineering at the University of Pittsburgh Swanson School of Engineering, has collaborated with researchers ...